Work

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Year: 2021
Type: article
Source: The Lancet
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W3130934287
FWCI: 81.58
Cites: 19
Cited by: 1,188
Related to: 10